AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15753425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal DC (1 mA)
Number of subjects: 103
Study 15753425 — intervention group
Group type: COMPARATOR
Intervention: Sham DC (1 mA)
Number of subjects: 103
Study 15753425 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal DC (2 mA)
Number of subjects: 103
Study 15753425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal DC (2 mA)
Number of subjects: 103
Study 12466165 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% once daily
Number of subjects: 28
Study 12466165 — intervention group
Group type: COMPARATOR
Intervention: Brimonidine tartrate 0.2% twice daily
Number of subjects: 28
Study 10071993 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia (GA) with fentanyl/propofol/rocuronium
Number of subjects: 60
Study 10071993 — intervention group
Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia (TEA) with propofol/rocuronium/epidural thoracic bupivacaine 0.5%
Number of subjects: 60
Study 7673542 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-contact cognitive bibliotherapy
Number of subjects: 80
Study 7673542 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 80
Study 2200931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 149
Study 2200931 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 149
Study 2200931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 2200931 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 149
Study 7024868 — intervention group
Group type: EXPERIMENTAL
Intervention: Azatadine maleate (Zadine) 2 mg twice daily
Number of subjects: 20
Study 7024868 — intervention group
Group type: EXPERIMENTAL
Intervention: Azatadine maleate (Zadine) 1 mg twice daily
Number of subjects: 20
Study 30784354 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 514
Study 30040589 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (CBT) for sexual dysfunction
Number of subjects: 69
Study 28213565 — intervention group
Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg every 4 weeks
Number of subjects: 60
Study 28213565 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 26416942 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical and intraurethral 2% lidocaine gel
Number of subjects: 133
Study 26416942 — intervention group
Group type: COMPARATOR
Intervention: Nonanesthetic lubricant (NAL)
Number of subjects: 133
Study 24211510 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg daily) for 28 days
Number of subjects: 171
Study 24211510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study 22475140 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine (600 mg/d until postpartum week 4)
Number of subjects: 220
Study 22475140 — intervention group
Group type: COMPARATOR
Intervention: Control (no telbivudine)
Number of subjects: 220
Study 22475140 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine
Number of subjects: 220
Study 22475140 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 220
Study 19881322 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) started on the first postoperative day with conventional physical therapy (n=29)
Number of subjects: 86
Study 19881322 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous passive motion (CPM) started on the third postoperative day with conventional physical therapy (n=29)
Number of subjects: 86
Study 19881322 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy only (control group, n=28)
Number of subjects: 86
Study 17760285 — intervention group
Group type: EXPERIMENTAL
Intervention: Local training (visually upright relative to the local module)
Number of subjects: 36
Study 17760285 — intervention group
Group type: EXPERIMENTAL
Intervention: Station training (constant orientation relative to the station)
Number of subjects: 36
Study 17760285 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed training (local followed by station orientation)
Number of subjects: 36
Study 17760285 — intervention group
Group type: COMPARATOR
Intervention: Egress testing trials (without the tour guide)
Number of subjects: 36
Study 14990635 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 Gy per two fractions (n = 146)
Number of subjects: 421
Study 14990635 — intervention group
Group type: EXPERIMENTAL
Intervention: 42 Gy per 15 fractions (n = 145)
Number of subjects: 421
Study 14990635 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Gy per 25 fractions (n = 130)
Number of subjects: 421
Study 11343232 — intervention group
Group type: EXPERIMENTAL
Intervention: Butyl cyanoacrylate injection (group A)
Number of subjects: 60
Study 11343232 — intervention group
Group type: COMPARATOR
Intervention: Band ligation (group B)
Number of subjects: 60
Study 9128987 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training (walking on a treadmill) for 6 weeks
Number of subjects: 16
Study 9128987 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 16
Study 7968423 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with 0.45 kg hand weights (W1)
Number of subjects: 19
Study 7968423 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with 1.36 kg hand weights (W3)
Number of subjects: 19
Study 7968423 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with 2.27 kg hand weights (W5)
Number of subjects: 19
Study 7968423 — intervention group
Group type: COMPARATOR
Intervention: Walking with no weights (W0)
Number of subjects: 19
Study 7968423 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking with hand weights (W1, W3, W5) during constant heart rate (CHR)
Number of subjects: 19
Study 3297595 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 120 mg three times daily
Number of subjects: 21
Study 31417680 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelmeg (pegfilgrastim)
Number of subjects: 171
Study 28292551 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous paravertebral block at levels T1 and T2 with bupivacaine infusion
Number of subjects: 36
Study 28292551 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 36
Study 25731629 — intervention group
Group type: EXPERIMENTAL
Intervention: Vanutide cridificar (ACC-001) + QS-21 adjuvant
Number of subjects: 0
Study 25731629 — intervention group
Group type: COMPARATOR
Intervention: QS-21 alone
Number of subjects: 0
Study 25731629 — intervention group
Group type: COMPARATOR
Intervention: Phosphate-buffered saline
Number of subjects: 0
Study 23299960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate (151 mg per dose)
Number of subjects: 116
Study 23299960 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 116
Study 23299960 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate
Number of subjects: 116
Study 21110413 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Relearning Programme
Number of subjects: 0
Study 21110413 — intervention group
Group type: COMPARATOR
Intervention: Bobath approach
Number of subjects: 0
Study 19586230 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 526
Study 19586230 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 526
Study 17100370 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.025 mg/d transdermal estradiol
Number of subjects: 108
Study 17100370 — intervention group
Group type: COMPARATOR
Intervention: 0.05 mg/d transdermal estradiol
Number of subjects: 108
Study 15119922 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (up to 20 mg/day)
Number of subjects: 26
Study 15119922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 11231440 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP (30 ng/kg/min) infusion before and after ACEi treatment (n = 9)
Number of subjects: 17
Study 11231440 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of ANP with acute saline solution load (n = 8)
Number of subjects: 17
Study 11231440 — intervention group
Group type: COMPARATOR
Intervention: Acute saline solution loading (n = 8)
Number of subjects: 17
Study 9566811 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (maximal tolerated dose)
Number of subjects: 20
Study 9566811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8176138 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric evaluation and management (GEM)
Number of subjects: 154
Study 8176138 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 154
Study 8176138 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM
Number of subjects: 154
Study 2500196 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaling fully humidified air at 43 degrees C for 20 minutes
Number of subjects: 171
Study 2500196 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaling fully humidified air at 43 degrees C for 30 minutes on three occasions
Number of subjects: 171
Study 2500196 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaling fully humidified air at 43 degrees C for 20 minutes at the onset of the cold and for 10 minutes on succeeding days
Number of subjects: 171
Study 2500196 — intervention group
Group type: COMPARATOR
Intervention: Inhaling fully humidified air at 30 degrees C
Number of subjects: 171
Study 4400530 — intervention group
Group type: EXPERIMENTAL
Intervention: M & B 17803A (300 mg)
Number of subjects: 4
Study 4400530 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (10 and 40 mg)
Number of subjects: 4
Study 4400530 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 4
Study 4400530 — intervention group
Group type: EXPERIMENTAL
Intervention: M & B 17803A and Propranolol
Number of subjects: 4
Study 4400530 — intervention group
Group type: EXPERIMENTAL
Intervention: M & B 17803A (small oral doses)
Number of subjects: 4
Study 31371154 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical haemostatic agents (oxidized cellulose or collagen) + fibrin glue (experimental group with VADs)
Number of subjects: 60
Study 31371154 — intervention group
Group type: COMPARATOR
Intervention: Topical haemostatic agents (oxidized cellulose or collagen) (control group)
Number of subjects: 60
Study 30712955 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive respiratory muscle training (RMT) with trunk stabilization exercise (TSE)
Number of subjects: 33
Study 30712955 — intervention group
Group type: COMPARATOR
Intervention: Trunk stabilization exercise (TSE)
Number of subjects: 33
Study 28369078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower meal frequency (B2)
Number of subjects: 54
Study 28369078 — intervention group
Group type: COMPARATOR
Intervention: Six smaller meals a day (A6)
Number of subjects: 54
Study 28369078 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 54
Study 28369078 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating only breakfast and lunch (B2)
Number of subjects: 54
Study 26043724 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD9668 60 mg twice daily (BID)
Number of subjects: 36
Study 26043724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 26043724 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD9668 60 mg BID
Number of subjects: 36
Study 23704939 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg apomorphine
Number of subjects: 105
Study 23704939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 20980352 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic knee wraps (MKWs) with a static magnetic field (35 mT) for 12 weeks
Number of subjects: 50
Study 20980352 — intervention group
Group type: COMPARATOR
Intervention: Sham magnetic knee wraps
Number of subjects: 50
Study 20980352 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MKWs and sham)
Number of subjects: 50
Study 20980352 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic knee wraps (MKWs)
Number of subjects: 50
Study 18953498 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 gm IV MgSO(4)
Number of subjects: 127
Study 18953498 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive agent (parenteral or oral)
Number of subjects: 127
Study 18953498 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IV MgSO(4) and antihypertensive agent
Number of subjects: 127
Study 17286764 — intervention group
Group type: EXPERIMENTAL
Intervention: ReFacto
Number of subjects: 0
Study 17286764 — intervention group
Group type: COMPARATOR
Intervention: Advate
Number of subjects: 0
Study 15536901 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) with real-time visualization and registration using 3-D MR images
Number of subjects: 24
Study 11182730 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-open repair
Number of subjects: 22
Study 11182730 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery (control group)
Number of subjects: 22
Study 9875839 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 8300
Study 9875839 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8300
Study 7818631 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial treatment
Number of subjects: 1489
Study 7818631 — intervention group
Group type: COMPARATOR
Intervention: Untreated residents
Number of subjects: 1489
Study 3132034 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplement of 50 mg daily for 2 weeks
Number of subjects: 25
Study 3132034 — intervention group
Group type: COMPARATOR
Intervention: Control group (no zinc supplement)
Number of subjects: 25
Study 27609783 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-help program
Number of subjects: 53
Study 27609783 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention group (control)
Number of subjects: 53
Study 30817502 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography-guided percutaneous transthoracic needle biopsy (PTNB)
Number of subjects: 141
Study 28601273 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis-3 criteria for sepsis
Number of subjects: 1591
Study 28601273 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis-3 criteria for septic shock
Number of subjects: 1591
Study 28601273 — intervention group
Group type: COMPARATOR
Intervention: Not meeting Sepsis-3 criteria for sepsis
Number of subjects: 1591
Study 28601273 — intervention group
Group type: COMPARATOR
Intervention: Not meeting Sepsis-3 criteria for septic shock
Number of subjects: 1591
Study 26567090 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep intervention (two-hour group teaching session and four support calls over 2 weeks)
Number of subjects: 235
Study 26567090 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep intervention
Number of subjects: 235
Study 26567090 — intervention group
Group type: COMPARATOR
Intervention: Control teaching sessions (instruction on infant safety)
Number of subjects: 235
Study 26567090 — intervention group
Group type: COMPARATOR
Intervention: Control teaching sessions
Number of subjects: 235
Study 22495500 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical acupoint stimulation (group T)
Number of subjects: 120
Study 22495500 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing (group C1)
Number of subjects: 120
Study 22495500 — intervention group
Group type: COMPARATOR
Intervention: Graduated compression stockings (group C2)
Number of subjects: 120
Study 21610517 — intervention group
Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 12
Study 21610517 — intervention group
Group type: COMPARATOR
Intervention: Quiet Sitting (QS)
Number of subjects: 12
Study 18269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 0.015 mg/kg/IU/mL every 2 weeks for 28 weeks
Number of subjects: 40
Study 18269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 0.030 mg/kg/IU/mL every 2 weeks for 28 weeks
Number of subjects: 40
Study 18269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced doses of omalizumab (0.0015 or 0.0050 mg/kg/IU/mL every 2 weeks for 18 weeks)
Number of subjects: 40
Study 18269927 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete discontinuation of omalizumab therapy
Number of subjects: 40
Study 16440917 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention
Number of subjects: 205
Study 12850599 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance provision of emergency contraception (8 oral contraceptive pills containing 0.15 mg of levonorgestrel and 30 microg of ethinyl estradiol) and a 5-minute educational session
Number of subjects: 370
Study 12850599 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 370
Study 12850599 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance provision of emergency contraception
Number of subjects: 370
Study 10428220 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectron prosthesis
Number of subjects: 410
Study 10428220 — intervention group
Group type: COMPARATOR
Intervention: Charnley prosthesis
Number of subjects: 410
Study 10428220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Charnley and Spectron prostheses
Number of subjects: 410
Study 10428220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both systems
Number of subjects: 410
Study 10428220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hip arthroplasty
Number of subjects: 410
Study 7484285 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 2.5 mg
Number of subjects: 36
Study 7484285 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg
Number of subjects: 36
Study 7484285 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg
Number of subjects: 36
Study 7484285 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 2271372 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (8 g)
Number of subjects: 6
Study 2271372 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (8 g)
Number of subjects: 6
Study 2271372 — intervention group
Group type: COMPARATOR
Intervention: Water only
Number of subjects: 6
Study 7427048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigvaris medium compression below-knee stockings
Number of subjects: 30
Study 7427048 — intervention group
Group type: EXPERIMENTAL
Intervention: Sigvaris strong compression below-knee stockings
Number of subjects: 30
Study 7427048 — intervention group
Group type: COMPARATOR
Intervention: Eesiness NHS two-way stretch stockings
Number of subjects: 30
Study 7427048 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings (general)
Number of subjects: 30
Study 28190003 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive engagement with quitline (multisession counselling)
Number of subjects: 100
Study 28190003 — intervention group
Group type: COMPARATOR
Intervention: Reactive engagement with quitline (multisession counselling)
Number of subjects: 100
Study 28190003 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help materials only (study 2) proactive engagement
Number of subjects: 100
Study 28190003 — intervention group
Group type: COMPARATOR
Intervention: Self-help materials only (study 2) reactive engagement
Number of subjects: 100
Study 28190003 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive outreach with quitline
Number of subjects: 100
Study 28190003 — intervention group
Group type: COMPARATOR
Intervention: Reactive outreach with quitline
Number of subjects: 100
Study 28190003 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive outreach with self-help
Number of subjects: 100
Study 28190003 — intervention group
Group type: COMPARATOR
Intervention: Reactive outreach with self-help
Number of subjects: 100
Study 27513384 — intervention group
Group type: EXPERIMENTAL
Intervention: High HPV16 viral load
Number of subjects: 1097
Study 27513384 — intervention group
Group type: EXPERIMENTAL
Intervention: High HPV18 viral load
Number of subjects: 1097
Study 27513384 — intervention group
Group type: COMPARATOR
Intervention: Low HPV16 viral load
Number of subjects: 1097
Study 27513384 — intervention group
Group type: COMPARATOR
Intervention: Low HPV18 viral load
Number of subjects: 1097
Study 24992277 — intervention group
Group type: EXPERIMENTAL
Intervention: LED activation
Number of subjects: 16
Study 24992277 — intervention group
Group type: COMPARATOR
Intervention: LED-laser activation (300 mW/cm2)
Number of subjects: 16
Study 22398668 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg cilostazol
Number of subjects: 60
Study 22398668 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and clopidogrel
Number of subjects: 60
Study 20461791 — intervention group
Group type: EXPERIMENTAL
Intervention: 48-hour immobilization in a triangular sling (n = 46)
Number of subjects: 90
Study 20461791 — intervention group
Group type: COMPARATOR
Intervention: Normal activity without restrictions (n = 44)
Number of subjects: 90
Study 18321680 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine for 6 months
Number of subjects: 16
Study 18321680 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal volunteers)
Number of subjects: 16
Study 16446029 — intervention group
Group type: EXPERIMENTAL
Intervention: Ectopic expression of Su(Fu) in NCI‐H209 cells
Number of subjects: 0
Study 14585761 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPC‐480 TT genotype with normal levels of physical activity
Number of subjects: 966
Study 14585761 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPC‐480 TT genotype with vigorous physical activity
Number of subjects: 966
Study 14585761 — intervention group
Group type: COMPARATOR
Intervention: LIPC‐480 CC/CT genotype with normal physical activity (reference group)
Number of subjects: 966
Study 11056771 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (nodraparin calcium, Fraxiparine) administered according to body weight
Number of subjects: 200
Study 11056771 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 200
Study 8970281 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of heat for 1 min using an infant heel warmer
Number of subjects: 63
Study 8970281 — intervention group
Group type: COMPARATOR
Intervention: Control group (no heat applied)
Number of subjects: 63